Low P2Y12-specific platelet inhibition in clopidogrel-treated patients with coronary artery disease is common and not reliably detected by conventional aggregation tests

被引：0
|
作者：
Schaefer, Andreas [1 ]
Weinberger, Sarah [1 ]
Eigenthaler, Martin [1 ]
Ertl, Georg [1 ]
Bauersachs, Johann [1 ]
机构：
[1] Univ Wurzburg, Wurzburg, Germany
来源：
CIRCULATION | 2007年 / 116卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2041
引用
收藏
页码：442 / 442
页数：1
相关论文
共 50 条
  • [31] Impact of P2Y12-ADP receptor polymorphism on the efficacy of clopidogrel dose-adjustment according to platelet reactivity monitoring in coronary artery disease patients
    Bonello, Laurent
    Bonello-Palot, Nathalie
    Armero, Sebastien
    Bonello, Caroline
    Mokhtar, Omar Ait
    Arques, Stephane
    Dignat-George, Francoise
    Camoin-Jau, Laurence
    Paganelli, Franck
    THROMBOSIS RESEARCH, 2010, 125 (04) : E167 - E170
  • [32] Comparison of three common whole blood platelet function tests for in vitro P2Y12 induced platelet inhibition
    Joao D. Dias
    Torben Pottgiesser
    Jan Hartmann
    Daniel Duerschmied
    Christoph Bode
    Hardean E. Achneck
    Journal of Thrombosis and Thrombolysis, 2020, 50 : 135 - 143
  • [33] Comparison of three common whole blood platelet function tests for in vitro P2Y12 induced platelet inhibition
    Dias, Joao D.
    Pottgiesser, Torben
    Hartmann, Jan
    Duerschmied, Daniel
    Bode, Christoph
    Achneck, Hardean E.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (01) : 135 - 143
  • [34] Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
    Wallentin, Lars
    Varenhorst, Christoph
    James, Stefan
    Erlinge, David
    Braun, Oscar Oe
    Jakubowski, Joseph A.
    Sugidachi, Atsuhiro
    Winters, Kenneth J.
    Siegbahn, Agneta
    EUROPEAN HEART JOURNAL, 2008, 29 (01) : 21 - 30
  • [35] Impact of cangrelor on P2Y12 mediated platelet reactivity in patients with diabetes mellitus and coronary artery disease
    Gutierrez, J. L. Ferreiro
    Ueno, M.
    Alissa, R.
    Dharmashankar, K.
    Capodanno, D.
    Desai, B.
    Bass, T. A.
    Angiolillo, D. J.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S96 - S96
  • [36] Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromes
    Joshi, Rajiv R.
    Hossain, Rashed
    Morton, Allison C.
    Ecob, Rosemary
    Judge, Heather M.
    Wales, Clare
    Walker, Jemma V.
    Karunakaran, Arun
    Storey, Robert F.
    PLATELETS, 2014, 25 (06) : 416 - 422
  • [37] Impaired inhibition of P2Y12 by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention
    El Ghannudi, S.
    Ohlmann, P.
    Jesel, L.
    Radulescu, B.
    El Adraa, E.
    Crimizade, U.
    Wiesel, M. L.
    Gachet, C.
    Morel, O.
    ATHEROSCLEROSIS, 2011, 217 (02) : 465 - 472
  • [38] Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease
    Cavallari, Ugo
    Trabetti, Elisabetta
    Malerba, Giovanni
    Biscuola, Michele
    Girelli, Domenico
    Olivieri, Oliviero
    Martinelli, Nicola
    Angiolillo, Dominick J.
    Corrocher, Roberto
    Pignatti, Pier Franco
    BMC MEDICAL GENETICS, 2007, 8
  • [39] Switching P2Y12-receptor inhibitors in patients with coronary artery disease
    Rollini, Fabiana
    Franchi, Francesco
    Angiolillo, Dominick J.
    NATURE REVIEWS CARDIOLOGY, 2016, 13 (01) : 11 - 27
  • [40] Switching P2Y12-receptor inhibitors in patients with coronary artery disease
    Fabiana Rollini
    Francesco Franchi
    Dominick J. Angiolillo
    Nature Reviews Cardiology, 2016, 13 : 11 - 27
12345